October is Liver Cancer Awareness Month, a reminder that liver cancer is often silent until it is advanced. India recorded about 38,700 new cases and nearly 37,000 deaths in 2022, and many patients arrive when surgery is no longer possible. For…
Radiation Safety After PSMA Therapy: Information Guide
Lutetium-177 (Lu-177) PSMA therapy is one of the most important advances in advanced prostate cancer care, and one question comes up at almost every counselling session: will I be radioactive, and how do I protect my family? The honest answer is…
FAPI PET Scan vs FDG PET Scan
Choosing between an FDG PET scan and a FAPI PET scan can decide how early, and how accurately, a cancer is caught. Both are PET-CT imaging tests, but they “light up” cancer through completely different biological pathways, which is why one…
PSMA Therapy Eligibility and Side Effects
Most explanations of PSMA therapy eligibility stop at a checklist, and most explanations of side effects stop at a list of percentages. Neither actually answers the two things patients and families want to know once they’re past the basics: where exactly…
Emerging Role of Radio Theranostics in Recurrent Brain Tumor
Recurrent glioblastoma (GBM) or High-Grade Glioma (HGG) remains one of the most challenging neuro-oncological conditions, with limited survival benefit from conventional therapies. Emerging molecularly targeted approaches, particularly Lutetium-177–based peptide receptor radionuclide therapy (PRRT), are showing promise as innovative strategies for select…
RadioiodineTherapy(I-131)forThyroidCancer: How It Works and Who Needs It
Radioiodine Therapy, commonly known as iodine 131 treatment, is an important part ofmodern thyroid cancer treatment and is widely used in advanced nuclear medicine in India.This therapy is especially recommended after thyroid surgery to destroy any remainingthyroid tissue or microscopic cancer…
Lutetium vs Actinium: Choosing the Right Alpha or Beta Strategy
Lutetium-177 and Actinium-225 therapies are transforming precision cancer treatment in India, especially for advanced and metastatic prostate cancer. In recent years, targeted radionuclide therapy has emerged as one of the most advanced treatment options for complex cancers. A common question among…
Terbium-161 FAPI Therapy: A New Frontier for Hard-to-Treat Cancers
When cancer comes back after treatment—or doesn’t respond at all—it can feel like the options are running out. But science is moving fast, and a new therapy called Terbium-161 FAPI is offering fresh hope to patients with relapsed or refractory solid…
🌟 Terbium-161 DOTATATE: A New Option for Neuroendocrine Tumors That Resist Standard Treatment
Living with a neuroendocrine tumor (NET) can be a long journey filled with ups and downs. For many patients, Lutetium-177 DOTATATE (Lu-177 PRRT) has been a game-changer—slowing tumor growth and improving quality of life. But what happens when the tumor stops…
Terbium-161 PSMA Therapy: A New Hope for Advanced Prostate Cancer Patients Resistant to Lutetium-177 PSMA
For many men battling advanced prostate cancer, modern treatments like Lutetium-177 PSMA therapy have brought relief and extended life. But what happens when the cancer stops responding? That’s where a new therapy “Terbium-161 PSMA” is stepping in, offering fresh hope for…